Change of diagnoses and outcome of patients with early inflammatory joint diseases during a mean 13-month follow-up

Scandinavian Journal of Rheumatology

Volumn 36, Issue 3, 2007, Pages 194-197

  Savolainen, E ^a   Kautiainen, H ^b   Koivula, M K ^c   Luosujarvi R ^d   Risteli, J ^c   Kaipiainen Seppanen O ^e  

^a Kuopio Municipal Hospital   (Finland)

^b Medcare Foundation   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AURANOFIN; AUROTHIOMALATE; AZATHIOPRINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; CONNECTIVE TISSUE DISEASE; FEMALE; FOLLOW UP; HIP; HOSPITALIZATION; HUMAN; INFECTIOUS ARTHRITIS; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SACROILIAC JOINT; SHOULDER; SPONDYLOARTHROPATHY; SYNOVITIS; TREATMENT OUTCOME; UNDIFFERENTIATED ARTHRITIS; VIRAL ARTHRITIS;

ADULT; AGED; ARTHRITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34547405307     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740601089309     Document Type: Article

References (15)

1. Schumacher HR Jr, Habre W, Meador R, Hsia EC. Predictive factors in early arthritis: long-term follow-up. Semin Arthritis Rheum 2004;33:264-72.
2. Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Ilonen J, et al. Delay to institution of therapy and induction of remission using single-drug or combination disease modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002;4:894-8.
3. Berthelot JM, Saraux A, Maugars Y, Prost A, Le Goff P. The nosology-taxonomy of recent-onset arthritis: the experience of early-arthritis clinics. Semin Arthritis Rheum 2001;30:354-65.
4. Harrison B, Symmons D. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of literature. II. Outcome at three years. Rheumatology 2000;39:939-49.
5. Jansen LMA, van Schaardenburg D, van der Horst-Bruinsma IE, Dijkmans BAC. One year outcome of undifferentiated polyarthritis. Ann Rheum Dis 2002;61:700-3.
6. Machold KP, Stamm TA, Eberl GJM, Nell VKP, Dunky A, et al. Very recent onset arthritis: clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol 2002;29:2278-87.
7. Sampaio-Barros PD, Bertolo MB, Kraemer MH, Marques-Neto JF, Samara AM. Undifferentiated spondyloarthropathies: a 2-year follow-up study. Clin Rheumatol 2001;20:201-6.
8. Söderlin MK, Kastbom A, Kautiainen H, Leirisalo-Repo M, Strandberg G, Skogh T. Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity. Scand J Rheumatol 2004;33:185-8.
9. Nissilä M, Isomäki H, Kaarela K, Kiviniemi P, Martio J, Sarna S. Prognosis of inflammatory joint diseases. Scand J Rheumatol 1983;12:33-8.
10. Rantapää-Dahlqvist S. Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis. Scand J Rheumatol 2005;34:83-96.
11. Savolainen E, Kaipiainen-Seppänen O, Kröger L, Luosujärvi R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 Arthritis Survey. J Rheumatol 2003;30:2460-8.
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.
14. Koski JM, Anttila PJ, Isomäki HA. Ultrasonography of the adult hip joint. Scand J Rheumatol 1989;18:113-17.
15. Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005;52:36-41.